# Patients Response to Early Switch To Oral:Osteomyelitis Study

> **NCT02099240** · EARLY_PHASE1 · TERMINATED · sponsor: **Julio Ramirez** · enrollment: 11 (actual)

## Conditions studied

- Osteomyelitis

## Interventions

- **DRUG:** oral antibiotics
- **PROCEDURE:** intravenous antibiotics

## Key facts

- **NCT ID:** NCT02099240
- **Lead sponsor:** Julio Ramirez
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03-06
- **Primary completion:** 2018-11-07
- **Final completion:** 2018-11-07
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Not enough patient enrollment and lack of staffing
- **Last updated:** 2021-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099240, "Patients Response to Early Switch To Oral:Osteomyelitis Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02099240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*